Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Ann Neurol. 2014 Jul 22;76(3):393–402. doi: 10.1002/ana.24220

Figure 7. Summary of PET measures after completion of C3 or placebo infusion.

Figure 7

Quantification of (A) FD Kocc and (B) DTBZ BP at the end of the study. Data are the mean ± SEM of the nigral tracer uptake before MPTP, and at the end of the 2-month drug or placebo infusion. There was significant preservation of uptake for both tracers (FP Kocc p=0.038; DTBZ p=0.02) in the C3-treated group by repeated measures ANOVA, with Tukey’s post-hoc test. C3, n = 8; controls, n = 7.